Skip to content
AnalystLens

Tenet Healthcare 8-K Report, Executive Changes (Jun 5, 2025)

Reports
Leadership Changes
Filing Date
Filed June 5, 2025
Period End
May 30, 2025
Security
THC
In the record · 2016–202610-K1110-Q338-K176

THC filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 176 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Jan ’19Jan ’19
  2. Deal closed8-K · Dec ’20Dec ’20
  3. Leadership change8-K · Oct ’22Oct ’22
  4. Material agreement8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K filed June 5, 2025. Cited figures are marked; the original filing is the authoritative source.

Tenet Healthcare Corp. filed this Form 8-K to report that, on May 30, 2025, Lisa Y.

Foo was promoted to Chief Operating Officer, a newly created position at the Company, effective immediately. The filing states that Ms. Foo's biographical information appears in the Company's definitive proxy statement filed on April 11, 2025, and is incorporated by reference. The report is a narrow executive-appointment notice under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers).

It does not disclose financial results, compensation terms, or any other financial figures. The filing was signed June 5, 2025 by Thomas A. Arnst, Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary.

For investors, the principal takeaway is the creation of a new senior operating role and the elevation of Ms. Foo to it. The filing itself offers no detail on her responsibilities, reporting lines, or compensation arrangements.

Key Highlights

  1. Lisa Y. Foo was promoted to Chief Operating Officer of Tenet Healthcare Corporation on May 30, 2025, effective immediately.
  2. The COO position is described as newly created within the Company.
  3. Ms. Foo's biographical information is incorporated by reference from the definitive proxy statement filed April 11, 2025.
  4. The filing is a Item 5.02 disclosure concerning appointment of certain officers and does not report financial results or figures.
  5. Tenet's common stock (THC) and 6.875% Senior Notes due 2031 (THC31) are listed on the NYSE.
  6. The report was signed June 5, 2025 by Thomas A. Arnst, EVP, Chief Administrative Officer, General Counsel and Corporate Secretary.

Frequently Asked Questions

  1. What change in leadership did Tenet Healthcare announce?

    Lisa Y. Foo was promoted to Chief Operating Officer, a newly created position, effective May 30, 2025.

  2. Is the COO role new at Tenet?

    Yes. The filing states that the Chief Operating Officer position is a newly created position within the Company.

  3. Where can I find more information about Lisa Foo?

    The filing incorporates her biographical information by reference from the Company's definitive proxy statement filed on April 11, 2025.

  4. Does this filing disclose changes to Ms. Foo's compensation?

    No. The filing only reports the promotion and its effective date and does not describe any compensation arrangements.

  5. Does this 8-K include financial results or guidance?

    No. The filing addresses only the officer appointment under Item 5.02 and contains no financial results, guidance, or other financial figures.